Taiki Hakozaki
11PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Nov 30, 2023
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.Yuto Terashima, Taiki Hakozaki, Yuji Uehara
|Nov 24, 2023
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer.Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy
|Nov 11, 2022
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis.Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa
|Oct 17, 2022
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report.Yuto Terashima, Taiki Hakozaki, Susumu Takeuchi
|May 02, 2022
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations.Yuji Uehara, Kageaki Watanabe, Taiki Hakozaki
|Nov 11, 2021
First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status.Shigemasa Takamizawa, Yusuke Okuma, Yasuhiro Kato
Pageof 2
Frequent Collaborators
4 joint publications
Yusuke Okuma
4 joint publications
Yukio Hosomi
2 joint publications
Yuji Uehara
1 joint publications
Lisa Derosa
1 joint publications
Evan J Lipson
1 joint publications
Drew M Pardoll
1 joint publications
Cynthia L Sears
1 joint publications
Shigemasa Takamizawa
1 joint publications
Yuto Terashima
1 joint publications
Kazuo Kasahara
